Morten Graugaard is the founder of Orbis Medicines. Orbis Medicines has raised $125M in total funding. Latest round: Series A. Based in Copenhagen, Denmark.
Morten Graugaard is the CEO of Orbis Medicines, a Copenhagen-based biotech company focused on oral macrocycle drug discovery. He became CEO in February 2025 after serving as a former partner at Novo Holdings A/S, a global life science investment fund.
Full founder directory · Investor directory · Company funding database · Fundraising library